Bonraybio Co., Ltd. Stock Price

TWSE:6955 Community·NT$4.1b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

6955 Share Price Performance

NT$165.50

34.20 (26.04%)

NT$165.50

34.20 (26.04%)

NT$165.50

Fri, 13 Mar 26

Share Pricen/a

6955 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Flawless balance sheet with acceptable track record.

1 Risk

1 Reward

View Full Analysis

Bonraybio Co., Ltd. Key Details

Last Reported Earnings

Dec 31, 2025

Next Reporting Earnings

n/a

: 4.13
: 77.87%
: 33.46%
: 0%

View Full Analysis

About 6955

Founded: 2015
Employees: n/a
CEO: Zhenteng Xu
WebsiteView website: bonraybio.com

Bonraybio Co., Ltd., a development stage company, manufactures medical instruments and solutions for the male infertility market. The company provides LensHooke X12 PRO semen analysis systems; and LensHooke X1 PRO semen quality analyzers. It also provides consumables, such as CS3 semen test slides; CA0/CA1 sperm separation solutions; and CS1 semen test cassettes. In addition, the company provides X QC Reticles, X QC video tools, and X QC beads; sperm DNA fragmentation test kits; and S10 data consolidation software. Bonraybio Co., Ltd. was founded in 2015 and is based in Taichung, Taiwan.